Rubitection

Improving the early assessment and care management of dermatological, surgical, and vascular-related wounds

Company Self Description

There are 30 million people who suffer from chronic skin conditions/diseases who have no access to low-cost reliable tools to monitor the health of their skin. The lack of reliable assessment and detection tools have results in racial health disparities for people of color. Rubitection's skin health risk assessment and care management, the Rubitect Assessment System (RAS), improves the early assessment and care management of dermatological, surgical, and vascular-related wounds with an initial application to early bedsores detection. Bedsores, our initial market, are an $22 billion healthcare problem at affects 2.3 million each year killing 60K. If detected early they can be prevented, but the standard early detection technique is not reliable and has limited use on dark skin tones. The RAS addresses this problem by empowering any caregiver with the ability to detect early signs of skin inflammation, independent of skin color, to enable early detection and improve care management with data analytics for hospitals, nursing homes, and in-home care. Our vision is to become the standard tool for skin health assessment to improve access to quality care, remove the racial disparities with skin health assessment, and to save lives around the world.

Pitch Video

Want to learn more?

Visit Rubitection's website to learn more about their mission.

More Great Pitches

Click below to head back to the results page to browse more impactful investment winners.

Back to results page.